Wed. Oct 2nd, 2024

Chancellor suggests a new class of drugs that delay the development of Alzheimer’s symptoms could save the NHS billions, as the report suggests the cost of caring for people with the disease could rise to £94.1 billion by 2040<!-- wp:html --><p><a href="https://whatsnew2day.com/">WhatsNew2Day - Latest News And Breaking Headlines</a></p> <div> <h2>Chancellor suggests a new class of drugs that delay the development of Alzheimer’s symptoms could save the NHS billions, as the report suggests the cost of caring for people with the disease could rise to £94.1 billion by 2040</h2> <p class="author-section byline-plain">By Kate Pickles Health Editor for The Daily Mail </p> <p><a href="https://whatsnew2day.com/chancellor-suggests-a-new-class-of-drugs-that-delay-the-development-of-alzheimers-symptoms-could-save-the-nhs-billions-as-the-report-suggests-the-cost-of-caring-for-people-with-the-disease-could-ris/">Chancellor suggests a new class of drugs that delay the development of Alzheimer’s symptoms could save the NHS billions, as the report suggests the cost of caring for people with the disease could rise to £94.1 billion by 2040</a></p> </div><!-- /wp:html -->

WhatsNew2Day – Latest News And Breaking Headlines

Chancellor suggests a new class of drugs that delay the development of Alzheimer’s symptoms could save the NHS billions, as the report suggests the cost of caring for people with the disease could rise to £94.1 billion by 2040

Chancellor suggests a new class of drugs that delay the development of Alzheimer’s symptoms could save the NHS billions, as the report suggests the cost of caring for people with the disease could rise to £94.1 billion by 2040

By